ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing April 7, 2021, 4:00 pm ET:

Excellent Outcome for Pediatric Patients with High-Risk Hodgkin Lymphoma Treated with Brentuximab Vedotin and Risk-Adapted Residual Node Radiation (Original Report)
Monika Metzger, et al.
Request this article

Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems (Original Contribution) 
Divya A. Parikh, MD, et al.
Request this article

Non–Small-Cell Lung Cancer: Real-World Cost Consequence Analysis (Original Contribution) 
Alessandra Buja, MD, PhD, et al.
Request this article

Publishing April 6, 2021, 4:00 pm ET:

Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection and Chemotherapy: The Children’s Oncology Group ARAR0332 Protocol (Original Report)
Carlos Rodriguez-Galindo, et al.
Request this article

The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (Original Report)
Martin Fromm, et al.
Request this article

Predicting Outcomes in Men with Metastatic Non Seminomatous Germ-Cell Tumors (NSGCT): Results from the IGCCCG-Update  Consortium (Original Report)
Silke Gillessen, et al.
Request this article

Natural Language Processing to Identify Cancer Treatments With Electronic Medical Records (Original Report)
Jiaming Zeng, et al.
Request this article

Patient and Physician Attitudes Toward Telemedicine in Cancer Clinics Following the COVID-19 Pandemic (Original Report)
Chase Wehrle, et al.
Request this article

OncoAlert Round Table Discussions: The Global COVID-19 Experience (Special Article)
Gilberto Morgan, et al.
Request this article

Multinational Study to Assess Stress Levels Among the Health Care Workers of Radiation Oncology Community at the Outset of the
COVID-19 Pandemic 
(Original Report)
Jai Prakash Agarwal, et al.
Request this article

Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies (Special Article)
Carlos Barrios, et al.
Request this article

Long-Term Outcomes in a Multi-Center, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma (Original Report)
Robert Cook, et al.
Request this article

High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma (Original Report)
David Coffey, et al.
Request this article

Comprehensive Clinical and Molecular Characterization of KRAS G12C Mutant Colorectal Cancer (Original Report)
Jason Timothy Henry, et al.
Request this article

Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer (Original Report)
Edmond Michael Kwan, et al. 
Request this article

Published April 2, 2021, 4:00 pm ET:

Wee1 Inhibition in Recurrent Serous Uterine Cancer: Science Paving the Way in a Challenging Disease (Editorial)  
Amit Oza, et al.
Request this article

Mobile Application to Identify Cancer Treatment–Related Financial Assistance: Results of a Randomized Controlled Trial (Original Contribution)
Aaron Tarnasky, MPH, et al.
Request this article

Pathology Consultation Clinic for Patients With Cancer: Meeting the Clinician Behind the Microscope (Original Contribution)
Eliya Shachar, MD, et al.
Request this article

Are Regulations Safe? Reflections From Developing a Digital Cancer Decision- Support Tool (Special Article)
Ciarán D. McInerney, et al.
Request this article

Computing the Hazard Ratios Associated With Explanatory Variables Using Machine Learning Models of Survival Data (Original Report)
James Lu, et al.
Request this article

Published April 1, 2021, 4:00 pm ET:

Palbociclib for Residual High-Risk Invasive HR-Positive/HER2-Negative Early Breast Cancer – The Penelope-B Trial (Rapid Communication)
Sibylle Loibl, et al.
Request this article

Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study (Original Contribution)
John F. Deeken, MD, ISCI, et al.
Request this article

Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis (Original Contribution)
Edward Li, PharmD, MPH, et al.
Request this article

Comprehensive Clinical and Molecular Characterization of KRAS G12C Mutant Colorectal Cancer (Original Report)
Jason Timothy Henry, et al.
Request this article

The Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care (Original Report)
Joanne Ngeow, et al.
Request this article

Published March 31, 2021, 4:00 pm ET:

Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile (Original Report)
Diana Osorio, et al.
Request this article

User Experience With Low-Cost Virtual Reality Cancer Surgery Simulation in an African Setting (Original Report)
Eric Bing, et al.
Request this article

Epidemiologic Pattern of Cancer in Kathmandu Valley, Nepal: Findings of Population-Based Cancer Registry, 2018 (Original Report)
Ranjeeta Subedi, et al.
Request this article

Published March 30, 2021, 4:00 pm ET:

Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation (Special Article)
Partha Basu, et al.
Request this article

Published March 29, 2021, 4:00 pm ET:

Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer From SOLAR-1 (Original Report)
Fabrice Andre, et al.
Request this article

Mutations in BRCA1/2 and Other Panel Genes in Metastatic Breast Cancer Patients – Association With Patient and Disease Characteristics and Effect on Prognosis (Original Report)
Peter Fasching, et al.
Request this article

Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program (Original Contribution)
Vishal Vashistha, MD, et al.
Request this article

Evaluation of a Multidisciplinary Immunotherapy Toxicity Monitoring Program for Patients Receiving Ipilimumab for Metastatic Melanoma (Original Contribution)
Ines Menjak, MD, MSc, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.